|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.195
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.193
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.191
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.185
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.171
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.155
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.147
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.143
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.136
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.127
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.127
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.122
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.115
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.110
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.102
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.101
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.100
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.099
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.098
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.092
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.091
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.090
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.090
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.090
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.090
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.085
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.083
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.083
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.082
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.081
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.080
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.080
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.079
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.076
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.074
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.072
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.070
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.070
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.069
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.069
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.068
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.068
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.067
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.067
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.066
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.066
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.065
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.065
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.064
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.063
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.062
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.062
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.059
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.059
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.058
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.057
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.057
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.056
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.055
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.055
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.054
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.053
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.053
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.053
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.053
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.052
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.051
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.050
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.050
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.050
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.050
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.050
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.050
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.049
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.049
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.048
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.048
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.048
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.048
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.048
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.047
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.047
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.046
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.046
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.046
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.046
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.046
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.045
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.045
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.045
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.044
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.044
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.043
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.043
|
|
|
|
rna 3 end processing
|
GO:0031123 |
20 |
0.043
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.042
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.042
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.042
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.042
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.042
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.042
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.042
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.041
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.041
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.041
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.041
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.041
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.041
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.040
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.040
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.040
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.040
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.040
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.040
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.040
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.040
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.040
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.039
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.039
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.039
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.039
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.039
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.039
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.039
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.039
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.039
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.038
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.038
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.038
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.038
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.038
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.037
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.037
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.037
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.037
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.037
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.036
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.036
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.036
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.036
|
|
|
|
golgi to endosome transport
|
GO:0006895 |
3 |
0.036
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.036
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.036
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.035
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.035
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.035
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.035
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.034
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.034
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.034
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.034
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.034
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.034
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.034
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.034
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.033
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.033
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.033
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.033
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.032
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.032
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.032
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.032
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.032
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.032
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.032
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.031
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.031
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.031
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.031
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.031
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.031
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.031
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.030
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.030
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.030
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.030
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.030
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.030
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.030
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.030
|
|
|
|
positive regulation of cell proliferation involved in heart valve morphogenesis
|
GO:0003251 |
1 |
0.029
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.029
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.029
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.029
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.029
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.028
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.028
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.028
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.028
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.028
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.028
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.028
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.028
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.028
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.027
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.027
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.027
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.027
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.027
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.027
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.027
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.026
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.026
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.026
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.026
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.026
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.026
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.026
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.025
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.025
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.025
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.025
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.025
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.025
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.025
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.025
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.025
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.025
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.025
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.025
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.024
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.024
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.024
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.024
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.024
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.024
|
|
|
|
mrna 3 end processing
|
GO:0031124 |
16 |
0.024
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.024
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.024
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.024
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.024
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.023
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.023
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.023
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.023
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.023
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.023
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.023
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.023
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.023
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.023
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.023
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.023
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.022
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.022
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.022
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.022
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.022
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.022
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.022
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.022
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.022
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.022
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.021
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.021
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.021
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.021
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.021
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.021
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.021
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.021
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.021
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.021
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.020
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.020
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.020
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.020
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.020
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.020
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.020
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.020
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.020
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.020
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.020
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.020
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.020
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.020
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.019
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.019
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.019
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.019
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.019
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.019
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.019
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.019
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.019
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.019
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.019
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.019
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.019
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.019
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.019
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.019
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.018
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.018
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.018
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.018
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.018
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.018
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.018
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.018
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.018
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.018
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.018
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.018
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.018
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.018
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.018
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.018
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.018
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.018
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.017
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.017
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.017
|
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.017
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.017
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.017
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.017
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
4 |
0.017
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.017
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.017
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.017
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.017
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.017
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.017
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.017
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.017
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.017
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.017
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.017
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.017
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.016
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.016
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.016
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.016
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.016
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.016
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.016
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.016
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.016
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.016
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.016
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.016
|
|
|
|
regulation of transcription by chromatin organization
|
GO:0034401 |
0 |
0.016
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.016
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.016
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.016
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.016
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.015
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.015
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.015
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.015
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.015
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.015
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.015
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.015
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.015
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.015
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.015
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.015
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.015
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.015
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.015
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.015
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.015
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.015
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.015
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.015
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.015
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.015
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.015
|
|
|
|
positive regulation of ras protein signal transduction
|
GO:0046579 |
13 |
0.015
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.014
|
|
|
|
cochlear nucleus development
|
GO:0021747 |
4 |
0.014
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.014
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.014
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.014
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.014
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.014
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.014
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.014
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.014
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.014
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.014
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.014
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.014
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.014
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.014
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.014
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.014
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.014
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.013
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.013
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.013
|
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
39 |
0.013
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.013
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.013
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.013
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.013
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.013
|
|
|
|
axon target recognition
|
GO:0007412 |
4 |
0.013
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.013
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.013
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.013
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.013
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.013
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.013
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.013
|
|
|
|
localization within membrane
|
GO:0051668 |
4 |
0.013
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.013
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.013
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.013
|
|
|
|
spongiotrophoblast layer development
|
GO:0060712 |
15 |
0.013
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.013
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.013
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.012
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.012
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.012
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.012
|
|
|
|
mitotic chromosome condensation
|
GO:0007076 |
1 |
0.012
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.012
|
|
|
|
negative regulation of ripoptosome assembly involved in necroptotic process
|
GO:1902443 |
3 |
0.012
|
|
|
|
developmental pigmentation
|
GO:0048066 |
40 |
0.012
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.012
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.012
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.012
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.012
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.012
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.012
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.012
|
|
|
|
translation
|
GO:0006412 |
93 |
0.012
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.012
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.012
|
|
|
|
granulocyte activation
|
GO:0036230 |
10 |
0.012
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.012
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.012
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.012
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.012
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.012
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.012
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.012
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.012
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.012
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.012
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.012
|
|
|
|
substrate adhesion dependent cell spreading
|
GO:0034446 |
30 |
0.012
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.012
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.012
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.012
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.011
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.011
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.011
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.011
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.011
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.011
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
30 |
0.011
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.011
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.011
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.011
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.011
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.011
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.011
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.011
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.011
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.011
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.011
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.011
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.011
|
|
|
|
negative regulation of osteoblast differentiation
|
GO:0045668 |
30 |
0.011
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.011
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.011
|
|
|
|
nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:0000288 |
12 |
0.011
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.011
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.011
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.011
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.011
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.010
|
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.010
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.010
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.010
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.010
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.010
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.010
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.010
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.010
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.010
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.010
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.010
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.010
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.010
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.010
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.010
|
|
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.010
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.010
|
|
